Editor's Highlights—February 2025

Abstract Understanding the pathophysiology of inflammatory skin diseases, including psoriasis, atopic dermatitis (AD), and prurigo nodularis (PN), has led to the development of innovative treatments. In the February issue of the Journal, we provide insight into the global epidemiology and psychosocial impact of psoriasis. We also discuss the role of tissue‐resident memory T cells in disease recurrence and evaluate the effectiveness of tildrakizumab in treating difficult areas in psoriasis. A novel framework is introduced in AD research that integrates social determinants of health, emphasizing systemic inequities over biological factors. Additionally, a meta‐analysis identifies a strong bidirectional link between AD and PN, highlighting shared pathophysiological mechanisms and potential therapeutic opportunities.